Related Experiment Video
Updated: Feb 28, 2026

07:17
Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes
Published on: December 16, 2022
4.2K
Simple, Efficient CRISPR-Cas9-Mediated Gene Editing in Mice: Strategies and Methods
Benjamin E Low1, Peter M Kutny1, Michael V Wiles2
1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, 04609-1500, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 7, 2016
Summary
Precision genetic modification in mice is now efficient and economical using targeted nucleases. This enables rapid creation of accurate human disease models for research and therapeutic development.
Area of Science:
- Genetics
- Molecular Biology
- Genomics
Background:
- Targeted nucleases enable precise genome editing across diverse species.
- The mouse is an ideal model organism for genetic studies due to its biology and cost-effectiveness.
Purpose of the Study:
- To review strategies for designing single guide RNAs (sgRNAs) for targeted nucleases.
- To detail the practical processes for precision targeting and modification of the mouse genome.
- To outline the establishment of novel precision genetically modified mouse lines.
Main Methods:
- Utilizing targeted nucleases for high-efficiency, rapid, and economical genome modification.
- Employing homologous recombination alongside targeted nucleases for precise genomic tailoring.
- Generating genetically modified mouse models directly in zygotes from any mouse strain.
Main Results:
- Enabling precision nucleotide modification of the mouse genome.
- Facilitating the creation of accurate models for human diseases and conditions.
- Allowing sequential refinement of mouse models to better mimic human pathologies.
Conclusions:
- Targeted nucleases and homologous recombination offer powerful tools for mouse genome engineering.
- These advancements accelerate the development of sophisticated mouse models for disease research.
- Precision genetic modification in mice is crucial for understanding gene function and developing therapeutics.
Related Concept Videos
CRISPR/Cas9 Genome Editing
2.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.2K
CRISPR
58.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.3K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
In-vitro Mutagenesis
17.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.2K

